Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Droplet Starter System

July 19, 2010 8:27 am | Drug Discovery & Development | Product Releases | Comments

Dolomite has introduced the modular Syringe-based Droplet Starter System, which enables users to produce more than 10,000 monodispersed droplets per second, ranging from Ø20 to 250µm.


Refractive Index Detection

July 19, 2010 8:16 am | Product Releases | Comments

Wyatt Technology Corporation, a leader in absolute macromolecular characterization instrumentation and software, announces the launch of its brand new Refractive Index (RI) detection instrument - the Optilab T-rEX.


Novasep And instrAction Ally Over Chromatography

July 19, 2010 8:01 am | News | Comments

Novasep, a leading supplier of manufacturing solutions to the life science industries, and instrAction, a manufacturer of innovative chromatographic stationary phases for API purification processes, announced that they have entered into a strategic alliance.


Biofocus Collaborating With Bristol On Neuropathic Pain

July 19, 2010 7:52 am | News | Comments

BioFocus and the University of Bristol announced a new drug discovery collaboration aimed at developing treatments for chronic pain associated with diabetes (diabetic neuropathic pain).


Musashi Implicated In Blast-Crisis CML

July 19, 2010 7:42 am | News | Comments

Researchers at Duke University Medical Center have identified a mechanism that could explain how patients move into the worst phase of chronic myelogenous leukemia (CML).


Protein Helps Stem Cells Stay Pluripotent

July 19, 2010 7:27 am | News | Comments

Take a skin cell from a patient with Type 1 diabetes. Strip out everything that made it a skin cell, then reprogram it to grow into a colony of pancreatic beta cells.


FDA Grants Priority Review to Denosumab

July 19, 2010 7:10 am | News | Comments

Amgen announced that the U.S. Food and Drug Administration (FDA) has granted priority review designation to denosumab, a subcutaneous RANK Ligand inhibitor, for the treatment of bone metastases to reduce skeletal related events (SREs) in patients with cancer.


Abbott Presents PROGRESS Results

July 19, 2010 7:05 am | News | Comments

Abbott presented 48-week findings comparing an HIV regimen of its protease inhibitor, Kaletra, and Merck's integrase inhibitor, Isentress, to a traditional HIV regimen of Kaletra and the nucleotide/nucleoside reverse transcriptase inhibitors in Truvada in antiretroviral-naive adult patients.


New Flu Vaccine May Come Via Patch

July 19, 2010 6:29 am | by Randolph E. Schmid | News | Comments

One day your annual flu shot could come in the mail. At least that's the hope of researchers developing a new method of vaccine delivery that people could even use at home: a patch with microneedles.


Over 5 Million Now Taking AIDS Drugs

July 19, 2010 6:15 am | by Veronika Oleksyn | News | Comments

The number of people taking crucial AIDS drugs climbed by a record 1.2 million last year to 5.2 million overall, the World Health Organization said—but Bill Clinton says that's still not nearly enough.


Repeating Pipette

July 16, 2010 8:56 am | Product Releases | Comments

The HandyStep electronic repeating pipette from BRAND increases productivity and reproducibility for repetitive and serial pipetting tasks.


Potentiometric Titrator

July 16, 2010 8:49 am | Product Releases | Comments

JM Science’s Potentiometric Titrator (COM-1700) allows up to four different titrations to run in parallel at the same time. The COM-1700 has reliable high-speed communications with no response time lag and results appear in real-time.


Biochemical Analysis

July 16, 2010 8:42 am | Product Releases | Comments

ChromoTek has launched the bioimaging tools RFP-Trap and GFP-Booster. RFP-Trap is used to identify and pull down interaction partners of proteins tagged with RFP and GFP-Booster restores or increases the GFP signal in super-resolution microscopy.


Gilead Suing Lupin Over Ranexa

July 16, 2010 8:32 am | News | Comments

Gilead Sciences, Inc. announced that it has filed a lawsuit in U.S. District Court in New Jersey against Lupin Limited for infringement against Gilead's patents for Ranexa (ranolazine extended-release tablets).


Thermo And Intrinsic to Co-Develop Biomarker Assay

July 16, 2010 8:29 am | News | Comments

Thermo Fisher Scientific Inc. and Intrinsic Bioprobes (IBI) Inc., announced an alliance to co-develop and market a mass spectrometry solution that will enable researchers to perform quantitative, high-throughput, high-resolution protein biomarker assays.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.